These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 38697834
1. Light-Responsive Pt(IV) Prodrugs with Controlled Photoactivation and Low Dark Toxicity. Spector D, Bubley A, Zharova A, Bykusov V, Skvortsov D, Ipatova D, Erofeev A, Gorelkin P, Vaneev A, Mazur D, Nikitina V, Melnikov M, Pergushov V, Bunin D, Kuzmin V, Kostyukov A, Egorov A, Beloglazkina E, Akasov R, Krasnovskaya O. ACS Appl Bio Mater; 2024 May 20; 7(5):3431-3440. PubMed ID: 38697834 [Abstract] [Full Text] [Related]
2. Optimization of axial ligands to promote the photoactivation of BODIPY-conjugated platinum(IV) anticancer prodrugs. Yao H, Gunawan YF, Liu G, Tse MK, Zhu G. Dalton Trans; 2021 Oct 12; 50(39):13737-13747. PubMed ID: 34519297 [Abstract] [Full Text] [Related]
3. Biotin-Pt(IV)-Ru(II)-Boron-Dipyrromethene Prodrug as "Platin Bullet" for Targeted Chemo- and Photodynamic Therapy. Bera A, Nepalia A, Upadhyay A, Saini DK, Chakravarty AR. Inorg Chem; 2024 Sep 16; 63(37):17249-17262. PubMed ID: 39235210 [Abstract] [Full Text] [Related]
4. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug. Krasnovskaya OO, Akasov RA, Spector DV, Pavlov KG, Bubley AA, Kuzmin VA, Kostyukov AA, Khaydukov EV, Lopatukhina EV, Semkina AS, Vlasova KY, Sypalov SA, Erofeev AS, Gorelkin PV, Vaneev AN, Nikitina VN, Skvortsov DA, Ipatova DA, Mazur DM, Zyk NV, Sakharov DA, Majouga AG, Beloglazkina EK. ACS Appl Mater Interfaces; 2023 Mar 15; 15(10):12882-12894. PubMed ID: 36854172 [Abstract] [Full Text] [Related]
5. BODI-Pt, a Green-Light-Activatable and Carboplatin-Based Platinum(IV) Anticancer Prodrug with Enhanced Activation and Cytotoxicity. Yao H, Chen S, Deng Z, Tse MK, Matsuda Y, Zhu G. Inorg Chem; 2020 Aug 17; 59(16):11823-11833. PubMed ID: 32799491 [Abstract] [Full Text] [Related]
6. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer. Srinivasulu YG, Mozhi A, Goswami N, Yao Q, Xie J. ACS Appl Bio Mater; 2021 Apr 19; 4(4):3232-3245. PubMed ID: 35014410 [Abstract] [Full Text] [Related]
7. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity. Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H. Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585 [Abstract] [Full Text] [Related]
8. Alternative mechanism of action of the DNP PtIV prodrug: intracellular cisplatin release and the mitochondria-mediated apoptotic pathway. Krasnovskaya O, Spector D, Erofeev A, Gorelkin P, Akasov R, Skvortsov D, Trigub A, Vlasova K, Semkina A, Zyk N, Beloglazkina E, Majouga A. Dalton Trans; 2021 Jun 15; 50(23):7922-7927. PubMed ID: 34037020 [Abstract] [Full Text] [Related]
9. Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs. Shi H, Romero-Canelón I, Hreusova M, Novakova O, Venkatesh V, Habtemariam A, Clarkson GJ, Song JI, Brabec V, Sadler PJ. Inorg Chem; 2018 Nov 19; 57(22):14409-14420. PubMed ID: 30365308 [Abstract] [Full Text] [Related]
10. Strategy for Traceless Codrug Delivery with Platinum(IV) Prodrug Complexes Using Self-Immolative Linkers. Lee VEY, Lim ZC, Chew SL, Ang WH. Inorg Chem; 2021 Feb 01; 60(3):1823-1831. PubMed ID: 33464875 [Abstract] [Full Text] [Related]
11. An Anticancer PtIV Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic Effects. Kostrhunova H, Petruzzella E, Gibson D, Kasparkova J, Brabec V. Chemistry; 2019 Apr 05; 25(20):5235-5245. PubMed ID: 30740808 [Abstract] [Full Text] [Related]
13. Engineering liposomal nanoparticles of cholesterol-tethered amphiphilic Pt(iv) prodrugs with prolonged circulation time in blood. Datta P, Bang S, Yue Z, Beach T, Stilgenbauer M, Wang H, Bowers DJ, Kurokawa M, Xiao H, Zheng YR. Dalton Trans; 2020 Jun 23; 49(24):8107-8113. PubMed ID: 32490446 [Abstract] [Full Text] [Related]
14. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules. Babu T, Sarkar A, Karmakar S, Schmidt C, Gibson D. Inorg Chem; 2020 Apr 06; 59(7):5182-5193. PubMed ID: 32207294 [Abstract] [Full Text] [Related]
15. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug. Ma L, Lin X, Li C, Xu Z, Chan CY, Tse MK, Shi P, Zhu G. Inorg Chem; 2018 Mar 05; 57(5):2917-2924. PubMed ID: 29436828 [Abstract] [Full Text] [Related]
16. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance. Kang X, Wang Y, Chen Z, Wu Y, Chen H, Yang X, Yu C. Chem Commun (Camb); 2020 Sep 28; 56(76):11271-11274. PubMed ID: 32830841 [Abstract] [Full Text] [Related]
17. Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? Schmidt C, Babu T, Kostrhunova H, Timm A, Basu U, Ott I, Gandin V, Brabec V, Gibson D. J Med Chem; 2021 Aug 12; 64(15):11364-11378. PubMed ID: 34342437 [Abstract] [Full Text] [Related]
19. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Zhao Y, Woods JA, Farrer NJ, Robinson KS, Pracharova J, Kasparkova J, Novakova O, Li H, Salassa L, Pizarro AM, Clarkson GJ, Song L, Brabec V, Sadler PJ. Chemistry; 2013 Jul 15; 19(29):9578-91. PubMed ID: 23733242 [Abstract] [Full Text] [Related]
20. Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy. Tang L, Luo Y, Luo W, Sun G, Jiang Y, Zhang Z, Yue X, Li S, Liang L, Liu W, Hu J. Curr Protein Pept Sci; 2024 Jul 15; 25(10):797-813. PubMed ID: 38919078 [Abstract] [Full Text] [Related] Page: [Next] [New Search]